Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

GBS Inc. (GBS)

0.4732   -0.008 (-1.58%) 10-26 16:00
Open: 0.4808 Pre. Close: 0.4808
High: 0.4854 Low: 0.4507
Volume: 9,030 Market Cap: 7(M)

Technical analysis

as of: 2023-01-06 4:31:26 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.46     One year: 0.55
Support: Support1: 0.27    Support2: 0.22
Resistance: Resistance1: 0.39    Resistance2: 0.47
Pivot: 0.35
Moving Average: MA(5): 0.31     MA(20): 0.36
MA(100): 0.51     MA(250): 0.72
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 28.1     %D(3): 26.6
RSI: RSI(14): 27.9
52-week: High: 1.98  Low: 0.27
Average Vol(K): 3-Month: 49 (K)  10-Days: 41 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ GBS ] has closed above bottom band by 14.7%. Bollinger Bands are 4.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.33 - 0.33 0.33 - 0.33
Low: 0.29 - 0.3 0.3 - 0.3
Close: 0.31 - 0.31 0.31 - 0.31

Company Description

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Headline News

Fri, 03 Feb 2023
How Many COVID-19 Infections Go Unreported Due to At-Home ... - Contagionlive.com

Fri, 03 Feb 2023
Why is reimagining procurement through the Global Business ... - Ernst & Young

Thu, 02 Feb 2023
Analyzing Cases of Guillain-Barré Syndrome After COVID-19 ... - Contagionlive.com

Thu, 02 Feb 2023
PM Modi to be star speaker at ET GBS 2023 - Economic Times

Thu, 02 Feb 2023
Finding the Source of Gut Microbiome Transmissions - Contagionlive.com

Thu, 02 Feb 2023
New York City Declares Mpox Outbreak Is Over - Contagionlive.com

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 15 (M)
% Held by Insiders 1.347e+007 (%)
% Held by Institutions 9 (%)
Shares Short 112 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS 0
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 907.1
Return on Equity (ttm) -30.5
Qtrly Rev. Growth 437150
Gross Profit (p.s.) 0.13
Sales Per Share 0.13
EBITDA (p.s.) 0
Qtrly Earnings Growth -0.6
Operating Cash Flow 0 (M)
Levered Free Cash Flow -3 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 2.32
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 151860
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.